From the Departments of Neuropathology (M.O.M., J.A.R.N.) and Neurology
(K.W.M., I.B.), Institute of Neurological Sciences, Southern General Hospital;
and Acute Stroke Unit, Department of Medicine and Therapeutics, Gardiner
Institute, Western Infirmary (C.J.W., A.G.D., K.R.L.), Glasgow, Scotland.
Correspondence to Dr James A.R. Nicoll, Department of Neuropathology, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, UK. E-mail JARN1H{at}clinmed.gla.ac.uk
Background and
PurposePolymorphism of the apolipoprotein E gene
(APOE) may influence outcome after traumatic brain
injury and intracerebral hemorrhage, with the
MethodsAPOE genotypes were determined in
714 stroke patients: 640 ischemic stroke and 74
intracerebral hemorrhage patients. The survival
effect of the
ResultsAllele distribution matched the general population
with no difference between the ischemic and hemorrhagic groups.
Survival in the entire cohort was unaffected by
ConclusionsThe APOE
© 1998 American Heart Association, Inc.
Original Contributions
The Apolipoprotein E
4 Allele and Outcome in Cerebrovascular Disease
4 allele being associated with poorer prognosis. We investigated
APOE allele distribution in acute stroke and the
effect of the
4 allele on outcome.
4 allele was assessed with the use of a stratified
log-rank test. A Cox proportional hazards regression model was used to
estimate the independent effect of
4 dose (0, 1, or 2) on survival,
and logistic regression was used to determine the effect on 3-month
outcome (good if alive at home, poor if in care or dead).
4 dose. Improved
survival with increasing
4 dose was found in the ischemic
group (relative hazard=0.76 per allele; P=0.04). If
transient ischemic attacks were excluded, a trend for improved
survival persisted (P=0.06). With
intracerebral hemorrhage, a trend was seen
toward reduced survival with
4 (P=0.07, log-rank
test). Three-month outcome in the ischemic group was unaffected
by
4 dose, and a trend toward poorer outcome with
4 was seen for
intracerebral hemorrhage
(P=0.10).
4 allele had divergent
effects on survival and outcome in ischemic and hemorrhagic
strokes in this population. The reported adverse effect on patients
with intracerebral hemorrhage was supported.
The favorable survival effect on ischemic stroke patients
requires further study.
Key Words: apolipoproteins stroke outcome
This article has been cited by other articles:
![]() |
N A Martinez-Gonzalez and C L M Sudlow Effects of apolipoprotein E genotype on outcome after ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage J. Neurol. Neurosurg. Psychiatry, December 1, 2006; 77(12): 1329 - 1335. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-C Becher, J W Keeling, N McIntosh, B Wyatt, and J Bell The distribution of apolipoprotein E alleles in Scottish perinatal deaths J. Med. Genet., May 1, 2006; 43(5): 414 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Teasdale, G. D. Murray, and J. A. R. Nicoll The association between APOE {varepsilon}4, age and outcome after head injury: a prospective cohort study Brain, November 1, 2005; 128(11): 2556 - 2561. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. Grocott, W. D. White, R. W. Morris, M. V. Podgoreanu, J. P. Mathew, D. M. Nielsen, D. A. Schwinn, M. F. Newman, and for the Perioperative Genetics and Safety Outcomes Genetic Polymorphisms and the Risk of Stroke After Cardiac Surgery Stroke, September 1, 2005; 36(9): 1854 - 1858. [Abstract] [Full Text] [PDF] |
||||
![]() |
P D Leclercq, L S Murray, C Smith, D I Graham, J A R Nicoll, and S M Gentleman Cerebral amyloid angiopathy in traumatic brain injury: association with apolipoprotein E genotype J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 229 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Meschia Clinically Translated Ischemic Stroke Genomics Stroke, November 1, 2004; 35(11_suppl_1): 2735 - 2739. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Gaynor, M. Gerdes, E. H. Zackai, J. Bernbaum, G. Wernovsky, R. R. Clancy, M. F. Newman, A. M. Saunders, P. J. Heagerty, J. A. D'Agostino, et al. Apolipoprotein E genotype and neurodevelopmental sequelae of infant cardiac surgery J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 1736 - 1745. [Abstract] [Full Text] [PDF] |
||||
![]() |
W T Longstreth Jr, G D Schellenberg, C E Fahrenbruch, L A Cobb, M K Copass, and D S Siscovick Apolipoprotein E genotypes and outcome from out of hospital cardiac arrest J. Neurol. Neurosurg. Psychiatry, October 1, 2003; 74(10): 1441 - 1443. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Diaz-Arrastia, Y. Gong, S. Fair, K. D. Scott, M. C. Garcia, M. C. Carlile, M. A. Agostini, and P. C. Van Ness Increased Risk of Late Posttraumatic Seizures Associated With Inheritance of APOE{epsilon}4 Allele Arch Neurol, June 1, 2003; 60(6): 818 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Burgos, C. Ramirez, I. Sastre, M. J. Bullido, and F. Valdivieso Involvement of Apolipoprotein E in the Hematogenous Route of Herpes Simplex Virus Type 1 to the Central Nervous System J. Virol., October 25, 2002; 76(23): 12394 - 12398. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Liberman, W. F. Stewart, K. Wesnes, and J. Troncoso Apolipoprotein E {epsilon}4 and short-term recovery from predominantly mild brain injury Neurology, April 9, 2002; 58(7): 1038 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H.S. Leung, W.S. Poon, L.M. Yu, G. K.C. Wong, and H.K. Ng Apolipoprotein E Genotype and Outcome in Aneurysmal Subarachnoid Hemorrhage Stroke, February 1, 2002; 33(2): 548 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Weir, M. O. McCarron, K. W. Muir, A. G. Dyker, I. Bone, K. R. Lees, and J. A. R. Nicoll Apolipoprotein E genotype, coagulation, and survival following acute stroke Neurology, September 25, 2001; 57(6): 1097 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. McCarron, J. A.R. Nicoll, M. J. O'Leary, R. J.L. Waugh, A. I. Qureshi, and D. F. Hanley Spontaneous Intracerebral Hemorrhage N. Engl. J. Med., September 6, 2001; 345(10): 769 - 770. [Full Text] [PDF] |
||||
![]() |
T. Niskakangas, J. Ohman, M. Niemela, E. Ilveskoski, T. A. Kunnas, and P. J. Karhunen Association of Apolipoprotein E Polymorphism With Outcome After Aneurysmal Subarachnoid Hemorrhage : A Preliminary Study Stroke, May 1, 2001; 32(5): 1181 - 1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rosand, E. M. Hylek, H. C. O'Donnell, and S. M. Greenberg Warfarin-associated hemorrhage and cerebral amyloid angiopathy: A genetic and pathologic study Neurology, October 10, 2000; 55(7): 947 - 951. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. McCarron, K. W. Muir, J. A. R. Nicoll, J. Stewart, Y. Currie, K. Brown, and I. Bone Prospective Study of Apolipoprotein E Genotype and Functional Outcome Following Ischemic Stroke Arch Neurol, October 1, 2000; 57(10): 1480 - 1484. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hassan and H. S. Markus Genetics and ischaemic stroke Brain, September 1, 2000; 123(9): 1784 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Vauthey, G. R. de Freitas, G. van Melle, G. Devuyst, and J. Bogousslavsky Better outcome after stroke with higher serum cholesterol levels Neurology, May 23, 2000; 54(10): 1944 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. McCarron, K. L. Hoffmann, D. M. DeLong, L. Gray, A. M. Saunders, and M. J. Alberts Intracerebral hemorrhage outcome: Apolipoprotein E genotype, hematoma, and edema volumes Neurology, December 1, 1999; 53(9): 2176 - 2176. [Abstract] [Full Text] |
||||
![]() |
M. O. McCarron, D. Delong, and M. J. Alberts APOE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis Neurology, October 1, 1999; 53(6): 1308 - 1308. [Abstract] [Full Text] |
||||
![]() |
M. O. McCarron, J. A.R. Nicoll, A. Izumihara, N. Iwamoto, K. Yamashita, H. Ito, and T. Ishihara Surgery for Cerebral Amyloid Angiopathy–Related Hemorrhage • Response Stroke, June 1, 1999; 30(6): 1291 - 1291. [Full Text] [PDF] |
||||
![]() |
H. Sheng, D. T. Laskowitz, G. B. Mackensen, M. Kudo, R. D. Pearlstein, D. S. Warner, and C. Iadecola Apolipoprotein E Deficiency Worsens Outcome From Global Cerebral Ischemia in the Mouse • Editorial Comment Stroke, May 1, 1999; 30(5): 1118 - 1124. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |